Collectively, GZFL could reduce CCl4-induced liver fibrosis in vivo by inhibiting TGF-β1/Smad2/3, CUGBP1 signaling and activating IFN-γ/STAT1/Smad7 signaling. The gene discussed is IFNG; the disease is Hepatic fibrosis.